Professor of Surgery, University Tex Houston
General Surgery
Dr. John M. Skibber, MD
|
|
Give Review
Doctor John M. Skibber, MD practices General Surgery. He attended NYU School of Medicine. He received 4 awards: "America's Top Doctors", "Top Doctors:SE Texas", "America's Top Doctors for Cancer" and "Fellow (FACS)". John Skibber is a published physician as well. He has 69 publications published. The latest was: Overtreatment of Young Adults With Colon Cancer: More Intense Treatments With Unmatched Survival Gains. John Skibber accepts Medicare payments and is registered with Medicare.gov.
Publications
- Time Trend Analysis of Primary Tumor Resection for Stage IV Colorectal Cancer: Less Surgery, Improved Survival.
- Overtreatment of Young Adults With Colon Cancer: More Intense Treatments With Unmatched Survival Gains.
- Incidence of minimally invasive coloRectal cancer surgery at National Comprehensive Cancer Network centers.
- Increasing Disparities in the Age-Related Incidences of Colon and Rectal Cancers in the United States, 1975-2010.
- Functional Deficits and Symptoms of Long-Term Survivors of ColoRectal Cancer Treated by Multimodality Therapy Differ by Age at Diagnosis.
- Definitive Chemoradiation for Squamous Cell Carcinoma of the Rectum.
- Intraoperative radiation therapy for locally advanced primary and recurrent coloRectal cancer: Ten-year institutional experience.
- Neoadjuvant Radiotherapy Use in Locally Advanced Rectal Cancer at NCCN Member Institutions.
- Postoperative chemotherapy use after neoadjuvant chemoradiotherapy for rectal cancer: Analysis of Surveillance, Epidemiology, and End Results-Medicare data, 1998-2007.
- Preoperative Radiation Therapy With Concurrent Capecitabine, Bevacizumab, and Erlotinib for Rectal Cancer: A Phase 1 Trial.
- Quantified pathologic response assessed as residual tumor burden is a predictor of recurrence-free survival in patients with Rectal cancer who undergo resection after ...
- Impact of Ileostomy-Related Complications on the Multidisciplinary Treatment of Rectal Cancer.
- Long-term results of weekly/daily cisplatin-based chemoradiation for locally advanced squamous cell carcinoma of the Anal cAnal.
- Localized Colon Cancer, Version 3.2013.
- An individualized conditional survival calculator for patients with Rectal cancer.
- Metformin use and improved response to therapy in Rectal cancer.
- Metastatic Colon Cancer, Version 3.2013: Featured Updates to the NCCN Guidelines.
- Comparative Analysis of lymph node metastases in patients with ypT0-2 rectal cancers after neoadjuvant chemoradiotherapy.
- Postoperative adjuvant chemotherapy use in patients with stage II/III rectal cancer treated with neoadjuvant therapy: a national comprehensive cancer network Analysis.
- Multimodality salvage of recurrent disease after local excision for Rectal cancer.
- The association between psychosocial and medical factors with long-term sexual dysfunction after treatment for coloRectal cancer.
- Morbidity of Staged Proctectomy After Hepatectomy for Colorectal Cancer: A Matched Case-Control Analysis.
- Neoadjuvant Treatment Response As an Early Response Indicator for Patients With Rectal Cancer.
- Clinicopathology and Outcomes for Mucinous and Signet Ring Colorectal Adenocarcinoma: Analysis from the National Cancer Data Base.
- Pretreatment high-resolution Rectal MRI and treatment response to neoadjuvant chemoradiation.
- Reverse-hybrid robotic mesoRectal excision for Rectal cancer.
- Colon Cancer.
- Prognostic value of quality of life and Pain in patients with locally recurrent rectal cancer.
- Long-Term Follow-Up and Individual Item Analysis of Quality of Life Assessments Related to Laparoscopic-Assisted Colectomy in the COST Trial 93-46-53 (INT 0146).
- Number of lymph nodes examined and prognosis among pathologically lymph node-negative patients after preoperative chemoradiation therapy for Rectal adenocarcinoma.
- Long-term survival and recurrence outcomes following surgery for distal Rectal cancer.
- Multidisciplinary approach to recurrent/unresectable Rectal cancer: how to prepare for the extent of resection.
- Hyperfractionated accelerated radiotherapy for Rectal cancer in patients with prior pelvic irradiation.
- Molecular biomarkers correlate with disease-free survival in patients with Anal cAnal carcinoma treated with chemoradiation.
- Phase II trial of neoadjuvant bevacizumab, capecitabine, and radiotherapy for locally advanced Rectal cancer.
- Local excision after preoperative chemoradiation results in an equivalent outcome to total mesoRectal excision in selected patients with T3 Rectal cancer.
- Clinical significance of acellular mucin in Rectal adenocarcinoma patients with a pathologic complete response to preoperative chemoradiation.
- Practical application of a calculator for conditional survival in colon Cancer.
- Lymph node status after neoadjuvant radiotherapy for Rectal cancer is a biologic predictor of outcome.
- Concordance with NCCN Colorectal Cancer Guidelines and ASCO/NCCN Quality Measures: an NCCN institutional Analysis.
- A twenty-year experience with adenocarcinoma of the Anal cAnal.
- Sacral insufficiency fractures after preoperative chemoradiation for Rectal cancer: incidence, risk factors, and clinical course.
- The surgical instrument counting process: a statistician's plea for terminology clarification.
- Age-, race-, and ethnicity-related differences in the treatment of nonmetastatic Rectal cancer: a patterns of care study from the national cancer data base.
- Patterns of locoregional recurrence after surgery and radiotherapy or chemoradiation for Rectal cancer.
- Sentinel lymph node evaluation does not improve staging accuracy in colon Cancer.
- Are we undertreating Rectal cancer in the elderly? An epidemiologic study.
- Predictors and patterns of recurrence after definitive chemoradiation for Anal cancer.
- Pelvic exenteration affords safe and durable treatment for locally advanced Rectal carcinoma.
- Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for Rectal cancer.
- NCCN task force report: positron emission tomography (PET)/computed tomography (CT) scanning in Cancer.
- Barriers to rehabilitation of coloRectal cancer patients.
- Lymph node evaluation and survival after curative resection of colon Cancer: systematic review.
- Capecitabine and timing of radiotherapy during preoperative chemoradiation for Rectal cancer.
- Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the Anal cAnal.
- Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: a matched-pair Analysis.
- Phase II study of capecitabine (Xeloda) and concomitant boost radiotherapy in patients with locally advanced Rectal cancer.
- Clinical and pathologic predictors of locoregional recurrence, distant metastasis, and overall survival in patients treated with chemoradiation and mesoRectal excision...
- Pelvic exenteration for advanced pelvic Malignancies.
- Outcome after curative resection for locally recurrent Rectal cancer.
- Surgical implications of coloRectal cancer genetics.
- En bloc resection of primary sacral Tumors: classification of surgical approaches and outcome.
- Local excision for Rectal cancer.
- Predicting the node-negative mesorectum after preoperative chemoradiation for locally advanced Rectal carcinoma.
- The addition of continuous infusion 5-FU to preoperative radiation therapy increases tumor response, leading to increased sphincter preservation in locally advanced re...
- Response to preoperative chemoradiation increases the use of sphincter-preserving surgery in patients with locally advanced low Rectal carcinoma.
- Pain and quality of life after treatment in patients with locally recurrent rectal cancer.
- Sacrococcygeal ganglioneuroma.
Schools
Jefferson Med CollThos Jefferson Univ
New York University
University Tex MD Anderson
Procedures Preformed
- Biopsy of Breast
- Colectomy
- Cystectomy
- Cystotomy
- View All
Conditions Treated
- Abdominal Pain
- Anal and Rectal Cancer
- AnoRectal Abscess
- Atelectasis
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Amerigroup (Wellpoint)
- Blue Card PPO
- Blue Choice
- Carecentrix Health Plan
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- First Health (Coventry Health Care) PPO
- Golden Rule
- GEHA
- Choice Care PPO
- Medicaid
- Medicare MCR
- MHealth Insured
- MultiPlan PPO
- PHCS Network PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- America's Top Doctors
- Top Doctors:SE Texas
- America's Top Doctors for Cancer
- Fellow (FACS)
Education
-
National Institutes of Health Clinical Center -
NYU School of Medicine -
Jefferson Medical College
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1457445082 | |
| NPPES Provider LastName | SKIBBER | |
| NPPES Provider FirstName | JOHN | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Surgical Oncology | |
| Total Claim Count | 175.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 29.0 | |
| Percent Opioid Claims | 16.57 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1457445082 |
| Last Name Of The Provider | SKIBBER |
| First Name Of The Provider | JOHN |
| View All |
Similar Doctors
|
|
Dr. Gregory L. Smith, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sujit Prabhu, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ryan A. Lawless, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Paulette I. Abbas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jean T. Dolan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joo Y. Hwang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph F. Fernandez-Moure, MD |
|
|
Dr. Rafik M. Ghobrial M D, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mirtha A. Gonzalez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael J. Moustoukas, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jason L. Muesse, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anthony Tannous, MD |